ARCHIMED

All figures cover the European funds tracked here since 1 January 2025, whether closed or still raising, and are compiled from public sources.

Tracked funds

1

Reported volume

€1,500m

Latest public closing

9 Sept 2026

Reported volume sums the public fund amounts tracked here, not the manager's firm-wide assets under management, so it may differ from totals on the manager's website.

French private equity firm specialised in healthcare buyouts.

Focus: Small and mid-cap growth buyouts in healthcare, including medtech, biopharma, healthcare IT, diagnostics and pharma services

9 September 2026: ARCHIMED MED IV reached its final close at €1.5bn, hard-capped, after less than six months of fundraising (company announcement).